Trial intelligence / Profile preview

Vitamin D status survey and calcitriol intervention study in hypertension patients with low 25-hydroxyvitamin D in Urumqi

ChiCTR-TRC-12001910Phase 4Completed

Sponsor
First Affiliated Hospital of Xinjiang Medical University
Start
Mar 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of calcitriol in essential hypertension and Vitamin D deficiency (VDD) (2 arms), sponsored by First Affiliated Hospital of Xinjiang Medical University. Primary endpoint: 25-hydroxyvitamin D. Started Mar 2011; status: completed.

02

Drugs

calcitriol
03

Conditions

essential hypertensionVitamin D deficiency (VDD)

Beyond the preview

Go deeper on ChiCTR-TRC-12001910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12001910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call